Autonomix Medical, Inc. AMIX

FY2026 · ended Mar 31, 2026 · Revenue $0 · Filed May 27, 2026

Autonomix Medical, Inc. (AMIX) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2026, which ended Mar 31, 2026, it reported revenue of $0 and a net loss of $16.7 million. Free cash flow was -$12.3 million.

Revenue (TTM)
$0
Net income (TTM)
$-16.11M
Operating cash flow (TTM)
$-13.22M
Free cash flow
$-12.29M
-85.7% vs prior year
EPS
—
Dividend per share
None
Shares outstanding
11.41M
+0.0% vs prior year
Net cash
—
Operating margin
—

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
AMIX (Nasdaq)
Fiscal year ends
March 31
Incorporated in
DE
Headquarters
The Woodlands, TX
SEC filer status
, Emerging growth company
SEC CIK
1617867

Other Surgical & Medical Instruments & Apparatus companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2026
Mar 31, 2026
FY 2025
Mar 31, 2025
FY 2024
Mar 31, 2024
Revenue
$0
$0
$0
Operating income
-$17.0M
-$11.6M
-$12.0M
Net income
-$16.7M
-$11.4M
-$15.4M
Operating cash flow
-$12.3M
-$8.3M
-$6.6M
Free cash flow
-$12.3M
—
-$6.6M
Total assets
$7.6M
$9.8M
$9.4M
Total liabilities
$1.7M
$1.7M
$1.8M
Stockholders' equity
$5.9M
$8.1M
$7.6M
Cash and investments
$7.0M
$9.1M
$8.6M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Officer or director change, Shareholder vote results
Nov 3, 2026 Oct 29, 2026
8-K Current report
Officer or director change
Sep 16, 2026 Sep 14, 2026
8-K Current report
Material agreement, Unregistered share sale, Other events
Aug 26, 2026 Aug 24, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Other events
Jul 28, 2026 Jul 28, 2026
8-K Current report
Material agreement, Unregistered share sale, Other events
Jul 15, 2026 Jul 13, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.